Filing Details
- Accession Number:
- 0001415889-16-005302
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-03-25 15:54:15
- Reporting Period:
- 2016-03-24
- Filing Date:
- 2016-03-25
- Accepted Time:
- 2016-03-25 14:54:15
- Original Submission Date:
- 2016-03-24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1109196 | Mabvax Therapeutics Holdings Inc. | MBVX | Pharmaceutical Preparations (2834) | 930987903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612051 | V. Jeffrey Ravetch | C/O Mabvax Therapeutics, Inc. 11535 Sorrento Valley Rd., Suite 400 San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-03-24 | 131,500 | $0.60 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale was made in connection with the satisfaction of tax liability.
Billionaire Hedge Funds
